Source:http://linkedlifedata.com/resource/pubmed/id/19794239
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
2009-10-7
|
pubmed:abstractText |
Amyloid-beta plaques are an Alzheimer's disease biomarker which present unique challenges for near-infrared fluorescence tomography because of size (<50 microm diameter) and distribution. We used high-resolution simulations of fluorescence in a digital Alzheimer's disease mouse model to investigate the optimal fluorophore and imaging parameters for near-infrared fluorescence tomography of amyloid plaques. Fluorescence was simulated for amyloid-targeted probes with emission at 630 and 800 nm, plaque-to-background ratios from 1-1000, amyloid burden from 0-10%, and for transmission and reflection measurement geometries. Fluorophores with high plaque-to-background contrast ratios and 800 nm emission performed significantly better than current amyloid imaging probes. We tested idealized fluorophores in transmission and full-angle tomographic measurement schemes (900 source-detector pairs), with and without anatomical priors. Transmission reconstructions demonstrated strong linear correlation with increasing amyloid burden, but underestimated fluorescence yield and suffered from localization artifacts. Full-angle measurements did not improve upon the transmission reconstruction qualitatively or in semi-quantitative measures of accuracy; anatomical and initial-value priors did improve reconstruction localization and accuracy for both transmission and full-angle schemes. Region-based reconstructions, in which the unknowns were reduced to a few distinct anatomical regions, produced highly accurate yield estimates for cortex, hippocampus and brain regions, even with a reduced number of measurements (144 source-detector pairs).
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1361-6560
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
21
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6201-16
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19794239-Alzheimer Disease,
pubmed-meshheading:19794239-Amyloid beta-Peptides,
pubmed-meshheading:19794239-Animals,
pubmed-meshheading:19794239-Brain,
pubmed-meshheading:19794239-Calibration,
pubmed-meshheading:19794239-Disease Models, Animal,
pubmed-meshheading:19794239-Humans,
pubmed-meshheading:19794239-Image Processing, Computer-Assisted,
pubmed-meshheading:19794239-Mice,
pubmed-meshheading:19794239-Mice, Transgenic,
pubmed-meshheading:19794239-Models, Statistical,
pubmed-meshheading:19794239-Optics and Photonics,
pubmed-meshheading:19794239-Reproducibility of Results,
pubmed-meshheading:19794239-Spectrometry, Fluorescence,
pubmed-meshheading:19794239-Spectrophotometry, Infrared
|
pubmed:year |
2009
|
pubmed:articleTitle |
Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models.
|
pubmed:affiliation |
The Harvard-MIT Division of Health Sciences and Technology, 77 Mass Ave., E25-519, Cambridge, MA 02139, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|